Friday, May 1, 2026

SK Hynix Secures 100 Trillion KRW Cash for AI Memory Dominance in 2026

SK Hynix CEO Kwak No-jung plans to secure over 100 trillion KRW for AI memory investments and aims for ADR listing in the U.S. market.

SaaSpocalypse in Korea: VCs Say “SaaS Premium Is Dead” After AI Agents — Only Vertical Winners Survive

Investment in SaaS is shifting towards AI-driven models, with VC firms focusing on redefining revenue structures amid changing market dynamics.

U.S. and South Korea Reaffirm Security Cooperation Following Trump’s State Visit and APEC Summit

The U.S. Embassy in South Korea hosted a reception to celebrate security cooperation during the APEC summit, emphasizing strong ties.

Tag: ophthalmic treatments

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.